The plain-language read
Hyaluronic acid (HA) is the major glycosaminoglycan of the skin extracellular matrix. With age, HA content decreases, contributing to dehydration and loss of elasticity. Topical HA at multiple molecular weights penetrates differentially: high-MW HA forms a hydrating film on the surface; low-MW HA penetrates the epidermis and stimulates endogenous synthesis.
- HA content declines significantly with age
- Molecular weight determines depth of action
- Polyglutamic acid holds 4x more water than HA per molecule
- HA must be applied to damp skin to function as humectant, not desiccant
Apply HA serum to damp skin and seal with an occlusive (squalane, ceramide cream). In low-humidity environments (sub 50% RH), HA can pull water from the skin if not sealed — context-dependent ingredient.
What this means for your routine
If you're targeting dryness, this research supports adding hyaluronic acid to your AM/PM routine.
If you're targeting dryness, this research supports adding polyglutamic acid to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
HA is the dominant skin GAG and decreases markedly with age. Multiple molecular weights serve distinct functions: HMW HA (>1MDa) provides surface hydration and substantivity; LMW HA (<50kDa) penetrates epidermis and may stimulate endogenous HA synthesis. Crosslinked HA injection remains best-evidence for volumetric correction.
Full abstract→
Hyaluronic acid (HA) is the major glycosaminoglycan of the skin extracellular matrix. With age, HA content decreases, contributing to dehydration and loss of elasticity. Topical HA at multiple molecular weights penetrates differentially: high-MW HA forms a hydrating film on the surface; low-MW HA penetrates the epidermis and stimulates endogenous synthesis. Crosslinked HA injection remains the gold standard for volumetric correction.
Original source →An Injectable Biopolymer Hydrogel Complex (PN/HA/B3) for Facial Skin Redensification and General Rejuvenation: Clinical Report on Device Safety and Efficacy.
This study evaluated the safety and effectiveness of HYDRAGEL A2, an injectable medical device containing hyaluronic acid (HA), polynucleotides (PN), and niacinamide, for improving facial skin quality. These ingredients are increasingly recognized for their synergistic effects in aesthetic medicine, with HA and PN providing hydration and skin support, and niacinamide offering anti-inflammatory and antioxidant properties. A prospective, open-label clinical investigation was conducted on 42 female subjects (mean age 45 ± 1 years, Fitzpatrick skin phototypes II-V) to assess skin elasticity, hydration, and mild skin depression correction following cheek area injections.
Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials.
The combination of recombinant human epidermal growth factor (rhEGF) and fractional carbon dioxide (CO2) laser therapy is increasingly used in the treatment of facial atrophic acne scars. This study aimed to systematically assess the efficacy and safety of rhEGF combined with fractional CO2 laser therapy for managing facial atrophic acne scars. PubMed, Embase, the Cochrane Library, Web of Science, CNKI (China National Knowledge Infrastructure), Wanfang, SinoMed, and VIP were searched from inception to July 29, 2025.
Applications of bakuchiol in dermatology: Systematic review of the literature.
Bakuchiol (BAK), a meroterpene phenol abundant in the plant Psoralea corylifolia, is an emerging cosmeceutical agent with promising anti-aging, anti-inflammatory, and antibacterial properties. The trend for "clean" skincare products and search for anti-aging retinoid alternatives have poised BAK as a "must-have" ingredient in skincare. Our aim was to review the data for the applications of BAK in dermatology.